Royal Bank of Canada’s Adeptus Health Inc ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-30,600
Closed -$55K 7085
2017
Q1
$55K Sell
30,600
-108
-0.4% -$606 ﹤0.01% 5099
2016
Q4
$235K Buy
+30,708
New +$565K ﹤0.01% 4379
2016
Q3
Sell
-136,918
Closed -$7.07M 6748
2016
Q2
$7.07M Buy
136,918
+134,588
+5,776% +$8.07M ﹤0.01% 1678
2016
Q1
$130K Buy
2,330
+2,125
+1,037% +$110K ﹤0.01% 4633
2015
Q4
$11K Sell
205
-2,610
-93% -$167K ﹤0.01% 5950
2015
Q3
$227K Buy
2,815
+1,489
+112% +$154K ﹤0.01% 4214
2015
Q2
$126K Buy
1,326
+897
+209% +$61.7K ﹤0.01% 4698
2015
Q1
$22K Sell
429
-4,729
-92% -$187K ﹤0.01% 5322
2014
Q4
$193K Buy
+5,158
New +$162K ﹤0.01% 4372

Other funds holding ADPT

Royal Bank of Canada's ADPT Position: Q2 2017 in Review

Royal Bank of Canada sold out of Adeptus Health Inc (ADPT) in Q2 2017, closing a stake of 30,600 shares — an estimated $55K sold.

Royal Bank of Canada first reported a position in ADPT in Q4 2014 and held it in 9 quarters. The position peaked at $7.07M in Q2 2016. 9 funds tracked by Wall St. Rank hold ADPT as of Q2 2017.

  • Royal Bank of Canada reported no remaining Adeptus Health Inc position as of Q2 2017 after selling out during the quarter.
  • Royal Bank of Canada sold 30,600 Adeptus Health Inc shares in Q2 2017, an estimated $55K.
  • Royal Bank of Canada first reported a position in Adeptus Health Inc in Q4 2014 and held it in 9 quarters.
  • Royal Bank of Canada's Adeptus Health Inc position peaked at $7.07M in Q2 2016.
  • 9 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q2 2017.

Based on Royal Bank of Canada's 13F filing for Q2 2017, filed 14 Aug 2017.